MHRA Company-led recall Imatinib 400mg capsules (3×10) (Cipla EU)

MHRA Company-led recall Imatinib 400mg capsules (3×10) (Cipla EU)

September 24, 2018

Date issued: 21st September 2018

Cipla (EU) Limited has informed MHRA that there is an error on the Patient Information Leaflet (PIL) for the above product: the dosage information for the indication CML is incorrect

Action

Pharmacists are asked to remove the defective PIL from affected cartons before dispensing and provide a copy of the correct PIL

Please ensure that existing patients are taking the correct dose and provide a copy of the correct PIL if necessary.

Company contact for medical information enquiries:

Cipla (EU) Ltd

Tel: 07826544512 or 07876612672

Email: Sabrina.Ebu@Cipla.com or Prashant.Shirode@Cipla.com

To view the alert please visit here. 

 



Posted in:


More Latest News >

EPS Phase 4 piloting

NHS Digital continues to pilot EPS Phase 4. All pharmacy staff need to be aware that they could receive a...

PSNC Job Opportunity: Office Administrator

PSNC (the Pharmaceutical Services Negotiating Committee) represents England’s community (high-street) pharmacies, and is looking to recruit an Office Administrator to...